Willis-Knighton seeking participants for COVID-19 treatment clinical trial Willis-Knighton Health System is searching for participants for a COVID-19 related clinical trial. The hospital system is expanding its clinical trial for the Regeneron monoclonal antibodies for outpatient treatment of people infected with COVID-19. Willis-Knighton is one of 120 sites nationwide and is the only site in the region selected for the Regeneron study. (Source: Pexels) By Alex Onken | April 5, 2021 at 12:04 PM CDT - Updated April 5 at 12:04 PM
SHREVEPORT, La. (KSLA) - Willis-Knighton Health System is searching for participants for a COVID-19 related clinical trial.
The hospital system is expanding its clinical trial for the Regeneron monoclonal antibodies for outpatient treatment of people infected with COVID-19.